Cargando…
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine
SARS-CoV-2 mRNA vaccines have demonstrated high efficacy and immunogenicity, but limited information is currently available on memory B cell generation and long-term persistence. Here, we investigated spike-specific memory B cells and humoral responses in 145 subjects, up to 6 months after the BNT16...
Autores principales: | Ciabattini, Annalisa, Pastore, Gabiria, Fiorino, Fabio, Polvere, Jacopo, Lucchesi, Simone, Pettini, Elena, Auddino, Stefano, Rancan, Ilaria, Durante, Miriam, Miscia, Michele, Rossetti, Barbara, Fabbiani, Massimiliano, Montagnani, Francesca, Medaglini, Donata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505800/ https://www.ncbi.nlm.nih.gov/pubmed/34650563 http://dx.doi.org/10.3389/fimmu.2021.740708 |
Ejemplares similares
-
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine
por: Ciabattini, Annalisa, et al.
Publicado: (2023) -
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV
por: Polvere, Jacopo, et al.
Publicado: (2023) -
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses
por: Pettini, Elena, et al.
Publicado: (2022) -
Computational Analysis of Multiparametric Flow Cytometric Data to Dissect B Cell Subsets in Vaccine Studies
por: Lucchesi, Simone, et al.
Publicado: (2019) -
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity?
por: Pettini, Elena, et al.
Publicado: (2021)